Pennantpark Investment

PNNT · NYSE

$2.88−$0.03 (−1.03%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $2.91

PNNT analyst rating

HoldConsensus of 5 analysts over the last 12 months. 20% rate it a buy.

Strong buy0
Buy1
Hold3
Underperform1
Sell0

12-month price target · 7 analysts

Average $5.00 (+73.5% upside)

Low: $4.04
Now: $2.88
High: $5.78

Upgrades and downgrades

The latest rating actions, newest first

PNNT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Truist Securities	May 19, 2026	Maintains	Buy	$6.00 → $5.00	63%
Oppenheimer	May 12, 2026	Maintains	Perform	$6.00 → $5.00	34%
Keefe, Bruyette & Woods	Apr 16, 2026	Maintains	Underperform	$5.00 → $4.50	36%
Keefe, Bruyette & Woods	Feb 13, 2026	Maintains	Underperform	$5.50 → $5.00	36%
Compass Point	Dec 3, 2025	Upgrade	Sell → Neutral	$5.75 → $5.50	55%
Truist Securities	Nov 26, 2025	Maintains	Buy	$8.00 → $7.00	63%
JP Morgan	Nov 26, 2025	Maintains	Neutral	$6.50 → $5.50	35%
Keefe, Bruyette & Woods	Nov 26, 2025	Maintains	Underperform	$6.25 → $5.50	36%

The case for and against

Updated May 14, 2026

Bull case

Pennant Park Investment is expected to generate positive earnings in the future with estimated ROEs of 5.2% in F2026 and 8.0% in F2027, indicating potential for growth. Although it experienced net losses in F2Q26 due to unrealized losses on its investments, its high quality diversified portfolio and focus on middle-market companies with attractive risk-reward potential make it a reliable investment option. With an estimated cost of equity of 10.75%, it is currently trading at a discount to its fair value, making it a good opportunity for investors.

Bear case

Pennant Park Investment is facing a number of challenges that may negatively impact its future performance. These include liquidity concerns, heightened competition for loans which could lead to decreased loan yields and pressure on return on equity, and dependence on capital markets for growth. Additionally, the company has a significant spillover income balance and a mix of credit metrics that are mostly negative. We estimate a fair value of $5.01/share, reflecting a 74% of book value. Due to these concerning factors, we rate the shares as Perform with a $5 price target.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.